Understanding the mechanisms of proteinuria: therapeutic implications - Wikidata - awgldk - TriplyDB

Understanding the mechanisms of proteinuria: therapeutic implications

Understanding the mechanisms of proteinuria: therapeutic implications

http://www.wikidata.org/entity/Q36100123

about

Value of Routine Dengue Diagnostic Tests in Urine and Saliva Specimens Yi qi qing re gao attenuates podocyte injury and inhibits vascular endothelial growth factor overexpression in puromycin aminonucleoside rat model.Benefits of pomegranate (Punica granatum Linn) fruit extracts to weight changes, total protein, and uric acid in white rats (Rattus norvegicus) as an animal model of acute renal failure.Fluorescence dilution technique for measurement of albumin reflection coefficient in isolated glomeruli.Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers.Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients.Urinary proteins induce lysosomal membrane permeabilization and lysosomal dysfunction in renal tubular epithelial cells.Chronic kidney disease progression: a retrospective analysis of 3-year adherence to a low protein diet.An Attempt to Establish a Common Animal Model for Hepatorenal Fibrosis in Rats.Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage.

P2860

Q24288750-C4074439-04BB-4DB8-9658-7FA2E28FF9A9 Q33748334-CD5169AD-D77F-4EF1-B601-DDC7256C142F Q36221204-2C437F76-7643-4DAB-A6D0-8B901B79CD90 Q36382099-8404DBCE-99A0-498F-9F9C-C3E42C3C3F07 Q37142447-0BD52B99-4CFA-4F67-82CB-19D64473B6AB Q37697564-DB169770-D267-46D6-9441-F28FB63B92AB Q38920178-C992D8F2-B07F-44AA-8F3C-CA135A5B3D10 Q38983731-66ECF24C-5759-4FB9-831D-459E6EC30F9F Q41395343-EE0DDA73-9C4A-44A2-AAFC-2EB023CCCD45 Q51253230-D77BD961-D6D4-41CE-A30B-E6087EB817F2

P2860

Understanding the mechanisms of proteinuria: therapeutic implications

http://www.wikidata.org/entity/Q36100123

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Understanding the mechanisms of proteinuria: therapeutic implications

@ast

Understanding the mechanisms of proteinuria: therapeutic implications

@en

type

label

Understanding the mechanisms of proteinuria: therapeutic implications

@ast

Understanding the mechanisms of proteinuria: therapeutic implications

@en

prefLabel

Understanding the mechanisms of proteinuria: therapeutic implications

@ast

Understanding the mechanisms of proteinuria: therapeutic implications

@en

P1433

Q36100123-86492C7E-048A-4E25-995E-073D836C2971

P1476

Q36100123-1EE4FB25-442E-4268-9BD9-3453DFD32A31

P2093

Q36100123-2695D04C-38B3-4574-889E-0D75B320C55C

Q36100123-425F6906-187A-4003-B17D-AC1B8F098949

Q36100123-4A69A02E-6747-4C48-98D0-DD32E1763F44

Q36100123-592E4180-8B6D-4340-AABD-A197AE99367E

Q36100123-97787F8D-B265-49FD-8D18-3B5E2BDAFA7A

Q36100123-99C23C40-8D3B-4815-BD9C-01C78636940A

P2860

Q36100123-00CC3B9B-44D2-4627-A594-DBB8725CC402

Q36100123-01AB8369-B3CF-4980-A891-B7A6C2479B06

Q36100123-06AB8A64-D994-4FDB-81EB-C1542BEECE97

Q36100123-0861BEB4-59BD-4157-B652-39363578E6F8

Q36100123-0E58C548-BA1A-4A36-8660-B6A76907DB64

Q36100123-0E95276A-A2F7-4809-BF67-A0222DA7E803

Q36100123-0FF80498-183B-42A6-A069-07323FC13B7C

Q36100123-12CB64E1-1871-45D0-B77D-530A10044F27

Q36100123-16B11F82-BAC5-4074-B995-5862F0334351

Q36100123-16B692ED-FA9F-4667-B31E-BFC8BAB4BE5A

P304

Q36100123-60A3BD52-F968-4CB8-A7CC-74EB1E7B2730

P31

Q36100123-C71F4BA9-6C2F-4B50-949D-3F94EDEFA718

P356

Q36100123-2BF8969C-D5B4-40FF-8512-1566545D2BC4

P478

Q36100123-3884D420-DF65-4DBD-9ADD-C21AF1057E37

P577

Q36100123-1821C78B-BD30-40B6-8BA7-34DF2D3A0BB9

P5875

Q36100123-C264A515-AFB0-4303-9389-74D8B7C3956D

P698

Q36100123-95A4C0F6-AE9D-4465-8650-C52424ADBADA

P932

Q36100123-75712C17-C983-4B6D-A50D-38756D3E0C84

P356

P1433

International Journal of Nephrology

P1476

Understanding the mechanisms of proteinuria: therapeutic implications

@en

P2093

F Di Gennaro

http://www.w3.org/2001/XMLSchema#string

G Cao

http://www.w3.org/2001/XMLSchema#string

Jorge E Toblli

http://www.w3.org/2001/XMLSchema#string

L Madalena

http://www.w3.org/2001/XMLSchema#string

M Angerosa

http://www.w3.org/2001/XMLSchema#string

P Bevione

http://www.w3.org/2001/XMLSchema#string

P2860

Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

APOL1 localization in normal kidney and nondiabetic kidney disease

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

VEGF inhibition and renal thrombotic microangiopathy

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death

Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy

P304

546039

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/546039

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230586920

http://www.w3.org/2001/XMLSchema#string

P698

22844592

http://www.w3.org/2001/XMLSchema#string

P932

3398673

http://www.w3.org/2001/XMLSchema#string